Just In
- 2 hrs ago Summer Style: 6 Must-Try Colors To Stay Fashionably Cool Like B-Town Divas!
- 4 hrs ago Belgian Man Cleared Of Drunk Driving Because His Body Produces Alcohol Due To A Rare Condition
- 4 hrs ago Amitabh Bachchan's Youthful Avatar In Kalki 2898 AD Is Impressive, Check Actors Who Sported Digital De-Aging!
- 4 hrs ago Full Moon In Scorpio In April 2024: How It Will Affect 12 Zodiac Signs
Don't Miss
- Movies Jackie Shroff's Heartfelt Plea To Keep India's Strays Cool in the Heatwave Is Something You Can’t Miss
- News PM Slams Cong On Pitroda's 'Inheritance Tax' Remark Says Its 'Dangerous Intentions' Coming To Fore
- Automobiles 2024 Kia Carens Secures 3-Star Adult & 5-Star Child Safety Ratings – Detailed Look
- Technology Gigabyte Unveils AORUS CO49DQ: A Curved QD-OLED Gaming Monitor for Immersive Entertainment
- Education Maharashtra Class 10th Result 2024 to be Released Soon; Check Minimum Marks Required to Qualify Maharashtra SS
- Finance 1:10 Split, 5 Bonus, 70% Dividend: Crorepati Defene PSU Hits New High, 108605% Returns; BUY For Long Term
- Sports DC vs GT My11Circle Prediction IPL 2024 Match 40: DEL vs GUJ Fantasy Tips & Expert Picks
- Travel Mumbai Opens BMC Headquarters For Exclusive Heritage Tour
Serum Institute Urges Govt To Fast-Track Movement Of Increasing Covishield Stock
Serum Institute of India (SII) has urged the government to fast-track the Covishield movement citing the difficulties being faced in production and cold chain space planning for other vaccines because of the increasing stock of its COVID-19 jab, official sources said on Sunday.
Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII, is learnt to have recently communicated to the Union Health Ministry that it has a manufactured stock of 24,89,15,000 Covishield doses and it is increasing every day.
In addition to the Covishield vaccine, the Pune-based firm also manufactures and supplies various life-saving vaccines to EPI, UNICEF and different countries, Singh is learnt to have told the ministry.
"To fulfil our domestic and global supply commitments, we have to plan our production/cold chain space/human resource well in advance. In view of continuous increase in the stock of Covishield, we are facing a lot of difficulties in production/cold chain space/human resource planning for other life-saving vaccines," an official source quoted Singh as having stated in the letter.
"In view of these facts, genuine difficulties and as this matter is directly concerned with the availability of various other life-saving vaccines in our country and the world at large, we request for your kind intervention for fast-track movement of our Covishield vaccine domestically and globally," Singh is learnt to have stated.
The Centre has allowed SII to export 50 Lakh doses of Covishied under the UN-backed COVAX global vaccine sharing programme to Nepal, Tajikistan and Mozambique. SII will also export Covishield to Bangladesh under COVAX, an official source said.
The Serum Institute will commence its Covid vaccine export under the COVAX programme from November 23 and Nepal will receive the first lot of Covishiled on November 24.
The government had in October permitted SII to export 10 lakh Covishield doses, each to Nepal, Myanmar and Bangladesh under the 'Vaccine Maitri' programme.
- wellnessCervical Cancer Vaccine: All You Need To Know About India's Self-Developed HPV Vaccine
- wellnessDCGI Approves India's First qHPV Vaccine Against Cervical Cancer
- kidsSerum Institute Seeks Covovax's Inclusion In Covid Vaccination Drive For 12 Years And Over
- wellnessDCGI Grants Emergency Use Authorisation To Covovax For 12-17 Years Age Group; Younger Age Groups To Follow
- healthReduce Gap Between 2nd Dose And Precaution Dose Of Covishield, Urges Serum Institute To Health Ministry
- healthSerum Institute CEO Hails WHO's Approval Of Covovax For Emergency Use
- healthGovernment Allows Serum Institute To Export 50 Lakh Covishield Doses Under Covax To 4 Nations
- healthCOVID-19 Vaccines and Heart Attacks: New Studies Show Different Results; What Are They?
- wellnessCorbevax Will Be Allowed As A Booster For Those Fully Vaccinated With Covishield Or Covaxin
- wellnessBooster Dose Of COVID Vaccine Needed To Fight Against Omicron: Study
- wellnessCovishield Dose Gap Reduced To 8-16 Weeks From 12-16
- healthEach Dose Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Getting Regular Market Approval